Protocol for a randomised controlled trial on smartphone- and web-based app for precision dosing and monitoring of lithium («PharmOracle») for improving adherence to therapy in patients with bipolar affective disorder or schizoaffective disorder
Protocol for a randomised controlled trial on smartphone- and web-based app for precision dosing and monitoring of lithium («PharmOracle») for improving adherence to therapy in patients with bipolar affective disorder or schizoaffective disorder. // Neuroscience Applied. – URL: https://www.sciencedirect.com/science/article/pii/S2772408526001419?dgcid=rss_sd_all
Protocol for a randomised controlled trial on smartphone- and web-based app for precision dosing and monitoring of lithium («PharmOracle») for improving adherence to therapy in patients with bipolar affective disorder or schizoaffective disorder. Neuroscience Applied. https://www.sciencedirect.com/science/article/pii/S2772408526001419?dgcid=rss_sd_all
“Protocol for a randomised controlled trial on smartphone- and web-based app for precision dosing and monitoring of lithium («PharmOracle») for improving adherence to therapy in patients with bipolar affective disorder or schizoaffective disorder.” Neuroscience Applied.
@article{article9631,
title = {Protocol for a randomised controlled trial on smartphone- and web-based app for precision dosing and monitoring of lithium («PharmOracle») for improving adherence to therapy in patients with bipolar affective disorder or schizoaffective disorder},
journal = {Neuroscience Applied},
url = {https://www.sciencedirect.com/science/article/pii/S2772408526001419?dgcid=rss_sd_all}
}